Skip to main content

Hematologic Disease

1
Pipeline Programs
3
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Bayer
BayerLEVERKUSEN, Germany
2 programs
1
KogenatePhase 41 trial
Recombinant Factor VIIIN/A1 trial
Active Trials
NCT00782470Completed38Est. Nov 2010
NCT00586521Completed20Est. Mar 2008
B. Braun
B. BraunGermany - Melsungen
1 program
Vortex port and Celsite portN/A1 trial
Active Trials
NCT00484848Completed200Est. Mar 2005
Jazz Pharmaceuticals
Jazz PharmaceuticalsCA - Palo Alto
1 program
CaphosolPHASE_21 trial
Active Trials
NCT01426295Completed92Est. Apr 2014

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
BayerKogenate
Jazz PharmaceuticalsCaphosol
BayerRecombinant Factor VIII
B. BraunVortex port and Celsite port

Clinical Trials (4)

Total enrollment: 350 patients across 4 trials

NCT00586521BayerKogenate

BAY14-2222 Prophylaxis and Joint Function Improvement (Adults)

Start: Feb 2006Est. completion: Mar 200820 patients
Phase 4Completed
NCT01426295Jazz PharmaceuticalsCaphosol

Pharmaco-economic Study of a New Medical Device Performed From the Perspective of the Hospital

Start: Apr 2011Est. completion: Apr 201492 patients
Phase 2Completed
NCT00782470BayerRecombinant Factor VIII

Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe Hemophilia A

Start: Dec 2007Est. completion: Nov 201038 patients
N/ACompleted
NCT00484848B. BraunVortex port and Celsite port

Functional Evaluation of Two Types of Totally Implanted Venous Ports

Start: Sep 2004Est. completion: Mar 2005200 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.